An employee demonstrates samples of Sputnik Light vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in this still image taken from video released May 6, 2021 by the Russian Direct Investment Fund (RDIF). The Russian Direct Investment Fund (RDIF)/Handout via REUTERS

Second batch of Sputnik Light COVID-19 vaccine arrives in Yangon

Officials from the Yangon Region Public Health and Medical Services Department received a total of 512,000 doses of Sputnik Light COVID-19 vaccines purchased from the Russian Federation yesterday morning at the Yangon International Airport.

Myanmar purchased a total of 1 million doses of the Russian-made COVID-19 vaccines, nearly a half of which 488,000 doses were transported to Myanmar in the first batch on 13 January, and this is the second batch.

Sputnik Light COVID-19 vaccine requires only one dose per person and will greatly contribute to the rapid coverage of the COVID-19 vaccine in Myanmar. The vaccines have been stored at the Central Vaccine Store Depot in Yangon and will be distributed to regions and states.

Source: The Global New Light of Myanmar

Russia-2-sskm

MoH receives 400,000 doses of Sputnik Light COVID-19 vaccines from Russia

The Ministry of Health received a total of 400,000 doses of Sputnik Light COVID-19 vaccines donated by the Russian Federation at Yangon International Airport yesterday evening. At the handover ceremony, Russian Ambassador Dr Nikolay Listopadov said the vaccines are donated to mark the Myanmar-Russia friendship and to support Myanmar’s efforts to eradicate COVID-19 disease. He said that Russia and Myanmar will continue to cooperate in the fight against the pandemic in a friendly manner.

Union Minister for Health Dr Thet Khaing Win expressed words of thanks. He said the third wave of COVID-19 in Myanmar was under control with the leadership of the the State Administration Council and the efforts of health workers in a timely manner, adding the importance of the vaccine to control the disease transmission and that the donated vaccines will greatly help in controlling the disease in Myanmar. The Union minister also said that Myanmar will cooperate with the Russian Federation in the fight against the pandemic in a friendly manner.

Afterwards, the Union minister concluded the handover ceremony after giving the certificate of honour. Then, matters in connexion with the enhancement of cooperation in the health sector between the two countries were discussed. The Sputnik Light vaccine phial can be administered one time only so as to ensure more coverage of vaccination in Myanmar. A total of 400,000 doses of the Sputnik Light vaccine donated by Russia arrived yesterday and a total of 600,000 doses of the Sputnik Light vaccine purchased from Russia will arrive in Myanmar on 16 January, it is learnt.

Source: The Global New Light of Myanmar

Omikron-Varyanti

Information release on detection of SARS-CoV-2 Variant Omicron

  1. The Ministry of Health is continuously conducting “COVID-19 Molecular Disease Surveillance”, and releasing information on the detection of SARS CoV-2 Variant Omicron from those who return by relief flights in a timely manner.
  2. The four laboratory samples of the COVID-19 virus of the returnees were sent to the National Health Laboratory and No (1) Defence Services General Hospital (1000-bed) on 9-1-2022 and the SARS-CoV-2 Variant Omicron was found in three laboratory samples.
  3. Three Myanmar nationals had tested positive for Omicron as they returned from India by the relief flight.
  4. The patients are admitted to designated hospitals for medical treatment and the passengers who returned together with them now undergo strict quarantine and lab tests.
  5. Therefore, it is announced that the ministry is stepping up the COVID-19 disease monitoring and containing measures, including disease prevention, control and treatment activities.

Ministry of Health

Source: The Global New Light of Myanmar

218020036_952972475550062_7329640870647302015_n_2_0

Over 20 mln people fully vaccinated in Myanmar as of 4 January

About 20.91 million people have been fully vaccinated against COVID-19 across the country as of 4 January 2020, according to a release from the Ministry of Health. The country is administrating the vaccines to 36.9 million people aged 18 and older.

As of 4 January, there are 15.96 million people completed full doses of the vaccine and about 4.94 million people received single doses of COVID-19, according to the Ministry. Myanmar has inoculated over 51 per cent of its population against COVID-19 so far. This year, the vaccination will continue to be given to targeted groups to improve vaccine coverage. Earlier, those above 65 years old were in the priority group to be jabbed.

Now, the priority lists for COVID-19 jabs have been increased and the lists include people above 55 years of age. Besides, COVID-19 vaccines have been provided to above 45 years starting from 17 October and to above 40 starting from 9 November, according to the ministry. Myanmar detected its first two COVID-19 positive cases on 23 March 2020. The Ministry also urged people should receive the full dose of the vaccine and those who have received the first dose to visit the nearest immunization location or near the scheduled date for the second dose. \

Source: The Global New Light of Myanmar

sb4niWHq-viber-sskm-1024x583

Nippon Foundation donates 2 mln Covaxin doses to Myanmar

Japan’s philantropic Nippon Foundation is to donate 2 million jabs of Covaxin to Myanmar this month, a total of 1 million jabs were delivered to Myanmar at the VIP lounge of Yangon International Airport at 10 am yesterday.

At the handover ceremony, Mr Mori Yuji, executive director of Nippon Foundation, handed over 1 million jabs of Covaxin to Dr Maung Maung Myint, President of the Myanmar Red Cross Society (MRCS), in the presence of Mr Maruyama Ichiro, Ambassador of Japan to Myanmar and Dr Tun Min, Deputy Director-General of Yangon Region Public Health Department.

The officials from Japanese Embassy to Myanmar and Nippon Foundation, and MRCS also attended the ceremony. The Nippon Foundation will contribute US$17 million worth 2 million doses of Covaxin to Myanmar and 1 million doses arrived at the Yangon Internaitonal Airport by Qatar Airways flight (QR8920) in the first batch. The second batch is scheduled to come by this airlines on 23 January with another 1 million doses.

Source: The Global New Light of Myanmar

thumbs_b_c_562d6bee393393c657a0cf654fe104aa

Announcement on Extension of the Precautionary Restriction Measures Relating to Control of the COVID-19 Pandemic until 31 January 2022

  1. With a view to the further strengthening of measures to contain the spread of the
    COVID-19 pandemic, the Ministry of Foreign Affairs of the Republic of the Union of Myanmar has issued the following announcements regarding temporary entry restrictions for visitors from all countries. All those restrictions were extended until 31 December 2021 by the Ministry’s announcement dated 30 November 2021.
    (a) Announcement dated 15 March 2020 regarding precautionary measures for all travellers visiting Myanmar;
    (b) Announcement dated 20 March 2020 regarding additional precautionary measures for travellers visiting Myanmar and temporary suspension of issuance of visa on arrival and e-visa;
    (c) Announcement dated 24 March 2020 regarding additional precautionary measures for travellers from all countries visiting Myanmar;
    (d) Announcement dated 28 March 2020 regarding temporary suspension of all types of visas (including social visit visas) and visa exemption services.
  2. In order to continue its effective response measures to protect the population of the country from the risks of importation and spread of the COVID-19, the Government of the Republic of the Union of Myanmar has decided to extend the afore-mentioned entry restriction measures until 31 January 2022.
  3. In case of urgent official missions or compelling reasons, foreign nationals, including diplomats and United Nations officials, who wish to travel to Myanmar by available relief or special flights, may contact the nearest Myanmar Mission for possible exceptions with regard to certain visa restrictions. However, all visitors must abide by existing directives issued by the Ministry of Health relating to the prevention and control of the COVID-19 pandemic.

Ministry of Foreign Affairs
Nay Pyi Taw
Dated. 1 January 2022

Source: The Global New Light of Myanmar

MoHS-1-mk

Second batch of Covishield vaccines purchased from India arrives at Yangon Int’l Airport

The Ministry of Health extensively conducts vaccination programmes in Nay Pyi Taw Union Territory and Regions/States according to the target groups. The 6.7 million doses in the second batch of Covishield purchased from India arrived at the Yangon International Airport yesterday, and the country received a total of 13.4 million doses of the vaccine.

These 6.7 million doses were received by the head of the Yangon Region Medical Services and Public Health Department. A total of 13.78 million people aged above 18 were fully vaccinated, while 5.37 million received first shots till 28 December. Therefore, inoculation covers more than 51 per cent of thepopulation as there are about 19.15 million people over 18 who were immunized more than one time. Moreover, the government launched vaccination for middle and high school students over 12 across the nation.

A total of 1.29 million students have been fully inoculated and 188,836 received their first shots. The Ministry of Health obtained 56.36 million doses of the vaccine 44.4 million doses of procurement and 11.96 million doses of donation. The government will continue the immunization processes accordingly to the target groups in 2022. The Ministry of Health urged the people to get vaccinated without fail and those who receive the first shots to have the second jabs on the due date or within the fixed period at the nearest vaccination sites and to participate in the processes actively.

Source: The Global New Light of Myanmar

shutterstock_2011221854_h1

Information Release on detection of SARSCoV-2 Variant Omicron virus

  1. The Ministry of Health is continuously conducting “COVID-19 Molecular Disease Surveillance”.
  2. Among those returning on Relief Flight, laboratory samples of the COVID-19 virus were sent to laboratories from the Department of Medical Research, National Health Laboratory, Tatmadaw Medical Research Unit as well as to regional laboratories under the auspices of the World Health Organization (WHO) for Omicron Real-Time PCR Testing and Genomic Sequencing Testing.
  3. Initiation of genetic testing of COVID-19 was carried out on (14-12-2021) on 30 laboratory samples found for the virus. According to the results obtained on (28-12-2021), the SARSCoV-2 Variant Omicron was found in the laboratory samples of four Myanmar nationals returning by Relief Flight from Dubai of UAE, and the SARS-CoV-2 Variant Delta virus was found in the other 26 laboratory samples.
  4. Only one in four persons diagnosed with the Omicron virus has normal symptoms and the other three have no symptom. All four were monitored at the treatment centres and discharged from the treatment centre due to good health. It is reported that the four persons are in good health at present.
  5. Therefore, the Ministry of Health is stepping up the COVID-19 disease monitoring and control activities plus disease prevention, control and treatment activities.

Ministry of Health

Source: The Global New Light of Myanmar

jpg

Of 13.4 mln doses of Covishield vaccine purchased from India, 6.7 mln arrive in Yangon

Out of 13.4 million doses of the Covishield vaccine purchased from India, 6.7 million doses in first batch arrived at the Yangon International Airport yesterday and were received by the team led by the Head of the Yangon Region Department of Medical Services and Public Health.

The Ministry of Health has been conducting the vaccination against the COVID-19 disease to target groups across the country and as of 27 December 2021, 13.45 million people aged over 18 have been fully vaccinated with two doses and 5.54 million people aged over 18 have been injected once. As it makes 19 million people over the age of 18 inoculated at least once, over 50 per cent of the target population have accessed the vaccination.

In addition, as above 12-year-old students have been jabbed, a total of 1.28 million students were fully immunized and 189,104 students have received vaccines once. The Ministry of Health has purchased 37.7 million COVID-19 vaccines and received 11.96 million doses as a donation, totaling 49.66 million doses. The vaccination will continue in the coming year 2022 to increase the vaccination coverage and the people are urged to receive full doses of the vaccine and those who have received the first dose to visit the nearest immunization centre in order to get jabbed for the second time and actively participate in the inoculation programme by the Ministry of Health.

Source: The Global New Light of Myanmar

mizzima_1_69

Myanmar signs purchasing, production agreement for 10 million doses of Sinopharm COVID vaccines

The signing ceremony of the agreement to purchase and produce Sinopharm COVID-19 vaccine in Myanmar was held yesterday evening at Lotte Hotel, in Mayangon Township, Yangon Region. Chairman of the Central Committee for Supervision of COVID-19 Vaccine Production Union Minister for Industry Dr Charlie Than, Union Minister for Health Dr Thet Khaing Win, Yangon Region Chief Minister U Hla Soe, Deputy Minister for Industry U Ko Ko Lwin, Yangon Region Minister for Natural Resources U Zaw Win, Director of the Medical Services of the Ministry of Defence Maj-Gen Ko Ko Lwin, Ambassador of the People’s Republic of China to Myanmar Mr Chen Hai, and officials from the Ministry of Health and the Ministry of Industry attended the ceremony.

First, Union Minister Dr Charlie Than said COVID-19 is a highly contagious disease that is now spreading around the world, and vaccination is the most effective way to prevent the spread of COVID-19. Efforts are also being made to develop the COVID-19 vaccine in various parts of the world. By 2021, Myanmar had purchased 26 million doses of the Sinopharm vaccine. According to the Ministry of Health, the Sinopharm COVID-19 vaccine has been shown to have fewer side effects and is more effective. Efforts were made to purchase the COVID-19 vaccine from Sinopharm CNBG as Ready to Fill Bulk. Today, the acquisition of RTF Bulk to produce 10 million doses of COVID-19 vaccine is a new step in cooperation between Myanmar and the People’s Republic of China.

In collaboration with Sinopharm CNBG, we hope to develop not only important vaccines for Myanmar’s healthcare sector but also other drugs. The Ministry of Industry is working to produce and distribute more medicines needed by the people, the Union minister continued. He also said that the upcoming Chinese New Year 2022 will be a “tiger” year, so wishing to have good health, happiness and success. Afterwards, Ambassador Mr Chen Hai of the People’s Republic of China to Myanmar said that the first step in cooperation between Myanmar and China was to develop the vaccine produced by Sinopharm CNBG in Myanmar. China is distributing the COVID-19 vaccines to 120 countries and is stepping up research to develop a special treatment for the disease, he said. At the time of the third wave of COVID 19 in Myanmar, China was the largest supplier of the COVID vaccine.

Most of the COVID-19 vaccines that have been injected in Myanmar are made in China, and the signing of the RTF Bulk Agreement will greatly assist in the control of the pandemic in Myanmar, the Ambassador continued. Next, Chairman Mr Jingzhen Liu of Sinopharm Group said Sinopharm CNBG is a leading manufacturer and exporter of pharmaceuticals in China. It is engaged in medical treatment and industry and is the second-largest pharmaceutical manufacturer in Asia. The World Health Organization (WHO) has approved the emergency use of Sinopharm COVID-19 vaccines produced by the company. He also said that he will continue to cooperate in the prevention and control of the pandemic in Myanmar through the virtual system. Next, an agreement to purchase 10 million RTF Bulk Doses of Sinopharm COVID-19 vaccine was signed by Managing Director of Myanmar Pharmaceutical Enterprise U Myo Zar Ni Win and Mr Yang on behalf of Sinopharm China National Biotech Group.

Source: The Global New Light of Myanmar